HilleVax Market Cap

HilleVax has a market cap or net worth of $625.24 million as of April 24, 2024. Its market cap has increased by 20.59% in one year.

Market Cap

625.24M

Enterprise Value

367.84M

1-Year Change

20.59%

Ranking

#2756

Market Cap Chart

Since the IPO on April 29, 2022, HilleVax's market cap has increased from $538.26M to $625.24M, an increase of 16.16%. That is a compound annual growth rate of 7.84%.

Market Cap History

Date	Market Cap	% Change
Apr 22, 2024	645.10M	5.53%
Apr 19, 2024	611.30M	3.70%
Apr 18, 2024	589.50M	-5.35%
Apr 17, 2024	622.80M	-3.68%
Apr 16, 2024	646.60M	-6.47%
Apr 15, 2024	691.30M	-7.49%
Apr 12, 2024	747.30M	0.78%
Apr 11, 2024	741.50M	6.03%
Apr 10, 2024	699.30M	-3.04%
Apr 9, 2024	721.20M	1.33%
Apr 8, 2024	711.70M	-1.39%
Apr 5, 2024	721.70M	0.14%
Apr 4, 2024	720.70M	-2.16%
Apr 3, 2024	736.60M	-5.30%
Apr 2, 2024	777.80M	-1.76%
Apr 1, 2024	791.70M	-4.21%
Mar 28, 2024	826.50M	6.47%
Mar 27, 2024	776.30M	-1.40%
Mar 26, 2024	787.30M	-3.53%
Mar 25, 2024	816.10M	-1.97%
Mar 22, 2024	832.50M	5.54%
Mar 21, 2024	788.80M	-1.49%
Mar 20, 2024	800.70M	-5.16%
Mar 19, 2024	844.30M	0.46%
Mar 18, 2024	840.40M	-3.61%

View and export this data all the way back to 2022. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Pharming Group	664.63M
Savara	647.91M
Aerovate Therapeutics	646.98M
The Pennant Group	642.87M
Cabaletta Bio	642.58M
SI-BONE	627.05M
Embecta	626.46M
Immunome	626.42M

Market Cap Rankings